The inspiration behind Testa Center
is a combination of what
the biotech entrepreneurial company
can do together with the industry
muscles from a large company.
[Lotta Ljungqvist, CEO, Testa Center] Testa Center is a major initiative within
the Swedish government and Cytiva. It opened in 2018.
It supports growth of
the life science industry,
both biology innovations.
technology and digital innovations.
[Jesper Hedberg, Director, Testa Center] The purpose of Testa Center is to make
possible for small research groups and
small companies to verify the innovation.
So we're a nonprofit organization that
provides a production-like environment
for test runs of products and procedures.
[Kevin Seaver, Cytiva] The Testa Center is a place
that allows our customers to come
in and develop their products.
We're able to use automation and digital
platform and coupled with Rockwell Automation
to be able to improve their
process and allow them to develop their
products faster and more efficiently.
[Hedberg:] Typically our clients here in
Testa Center are spearhead research groups
from the academia or startup companies on
the verge of scaling up their process.
So we enable them to do that to reach the
tipping point and to be able to validate
their production for full scale.
The silent revolution within personalized
healthcare that we have around us
today is making things possible that
was not possible to do five years ago.
[Ljungqvist:] The future of medicine is combining
new technologies and innovations
into more precision treatment.
That's something we call precision
medicine or personalized medicine.
You can get treated without side effects
and also more efficiently and quicker.
During the past three years,
roughly 35 different projects
have been in Testa Center.
They have moved their manufacturing
processes to larger scale.
They've been able to access
the technology and own
the expertise of manufacturing themselves.
They have been able to raise more
funding because they de-risk the project.
[Hedberg:] If we look at biological production,
we need innovations from everywhere
to be able to do this
faster and cheaper.
So of course biological innovations,
but also material science,
digital innovation,
technological innovation and much more.
In here in Testa Center, we
enable researchers to verify their
innovations to reach the market faster.
[Seaver:] It really all starts with the patient.
for Cytiva. We really have to understand
that we're changing people's lives.
We're able to provide equipment
and products and services to our
customers that are developing
lifesaving drugs for these patients.
So we not only work in the industrial
manufacturing space, with
good manufacturing processes,
but we also work in the
P.D. space, so process development.
So right from the laboratories all the
way up until the full manufacturing,
we have automation that transfers from
the lab and transfers all the way up
into scales up through the different
spaces into manufacturing. As we designed
our control system and our products,
we designed them to be extremely
flexible so that customers have
the option of making one therapy,
and then being able to pivot to
another therapy extremely quickly.
[Ljungqvist:] The combination of biotech companies
with a more entrepreneurial spirit
together with the industry is a way to
move and advance innovations quicker.
The combination of Cytiva's expertise
in technology for biopharmaceuticals
and Rockwell's expertise in automation
brings together these tools to advance
the new technologies and new medicines.
[Seaver:] Rockwell has continued to expand
their IToT platform.
They continue to expand broader
in the industry,
not only in controls and automation,
but also in data collection
and analytics and so forth,
and we're able to utilize all those
benefits that they're developing.
They're developing these products,
they're developing these processes
that Cytiva can use,
and they're the experts in
a lot of these areas,
we can bring our expertise together for
the better good of our industry.
[Hedberg:] Ultimately,
the goal is to provide better
health globally through quality,
speed and cost effectiveness.
[Ljungqvist:] When we collaborate,
when we do things together,
we can do dramatic changes and
improvements to help humankind.